Syndax Pharmaceuticals Inc
SNDX21.300USD
-0.300-1.39%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.85BMarket Cap
LossP/E TTM
Syndax Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
23.68M
--
EPS(YoY)
-3.72
-25.13%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 23.68M, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.723, with a year-on-year change of -25.13%.
What is the net income of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its net income was -318.76M, with a year-on-year change of -52.25%.
What is the net margin of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -1346.11%, with a year-on-year change of --.
What is the gross margin of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 96.51%, with a year-on-year change of --.
What is the debt-to-asset ratio of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 47.42%, with a year-on-year change of 1320723.12%.
What is the Return on Equity (ROE) of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -75.69%, with a year-on-year change of -84.67%.
What is the Return on Assets (ROA) of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -47.66%, with a year-on-year change of -26.35%.
What is the operating profit of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -339.67M, with a year-on-year change of -47.71%.
What are the current assets of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its current assets were 603.06M, with a year-on-year change of 3.82%.
What are the total assets of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its total assets of Syndax Pharmaceuticals Inc were 724.82M, with a year-on-year change of 18.26%.
What are the total liabilities of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Syndax Pharmaceuticals Inc were 436.69M, with a year-on-year change of 644.14%.
What is the total equity of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its total equity of Syndax Pharmaceuticals Inc was 288.12M, with a year-on-year change of -48.01%.
What is the net operating income of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Syndax Pharmaceuticals Inc was -318.76M, with a year-on-year change of -52.25%.
What is the net investment of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its net investment of Syndax Pharmaceuticals Inc was -219.78M, with a year-on-year change of -286.87%.
What is the net financing of Syndax Pharmaceuticals Inc?
According to Syndax Pharmaceuticals Inc's FY2024 earnings report, its net financing of Syndax Pharmaceuticals Inc was 353.37M, with a year-on-year change of 33.78%.
